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Background: The importance of diagnosing and treating co-occurring psychiatric disorders among substance
abusers in treatment has received much attention. The aim of this study was to investigate to which extent
co-occurring psychiatric disorders are diagnosed in a clinical population of substance abusers, and which factors
(including the use of MINI-Plus) that influence the diagnosing of co-occurring psychiatric disorders.
Methods: Patients (N = 275) who received inpatient substance use treatment in five different units in Northern
Norway participated in the study. The patients’ clinicians gave information on diagnoses given during the stay in
the units, and whether a systematic diagnostic tool was used for the diagnosing (MINI-Plus). Predictors of
independent co-occurring psychiatric disorders were examined utilizing hierarchical regression analysis.
Results: One third of the patients were given an independent psychiatric diagnosis. Less than half of the patients
were assessed using a diagnostic tool. The main predictor of diagnosing of independent psychiatric disorders was
the use of the diagnostic tool MINI-Plus. Younger patients and patients that used less alcohol, were given
independent psychiatric diagnoses more frequently.
Conclusions: The number of co-occurring independent psychiatric diagnoses was lower compared to other studies
using standardized diagnostic tools. The low number of patients assessed by such a tool, and the strong
relationship between the use of such a tool and the diagnosing of co-occurring psychiatric disorders, suggest that
the implementation of standardized diagnostic tools should be addressed in the units. Generally, patients suffering
from substance use disorders should be systematically screened for other psychiatric disorders, in order to improve
their treatment and health.
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The diagnosing and treatment of co-occurring psychi-
atric disorders in substance abusers has received consid-
erable attention [1,2]. A range of studies have found that
psychiatric disorders are highly prevalent among sub-
stance abusers. Population studies indicate that psychi-
atric disorders and substance use disorders (SUDs)
appear simultaneously among 30 – 40% of those with al-
cohol use disorders, and 40 – 50% of those with drug
use disorders [3-8]. Studies of patients with SUDs in treat-
ment report an even higher co-occurrence of psychiatric* Correspondence: rolf.wynn@gmail.com
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reproduction in any medium, provided the ordisorders [9-12]. Mood and anxiety disorders very often
co-occur with SUDs [5,13,14]. Recent systematic reviews
have revealed a strong association between depression and
substance use [15-17]. A Norwegian study using the Com-
posite International Diagnostic Interview [18] found that
85% of patients in a sample of substance abusers in treat-
ment qualified for a current Axis 1 disorder in addition to
the substance related disorder. The level of any anxiety
disorders was 78% and the prevalence of major depression
was 36%.
The identification of reliable and valid diagnoses of co-
occurring psychiatric disorders in substance abusers may
be problematic, especially as symptoms of SUD and
non-SUD disorders may overlap [1,2]. The somewhat
varying prevalence of SUD patients with co-occurring
non-SUD diagnoses found in different studies [3-18]td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sessment. The nature of the relationship between sub-
stance use disorders and other psychiatric disorders is
complex, and substance abuse may precede or follow
other psychiatric disorders [19]. Psychiatric disorders
may represent independent disorders, be related to acute
intoxication or substance withdrawal states, or be the
consequence of psychosocial stressors that many SUD
patients experience, such as unemployment, poverty,
loneliness, etc. [20,21]. Symptoms of anxiety, depression,
mania and psychoses are all commonly induced by vari-
ous substances and can be observed with chronic use as
well as during specific substance-induced states; includ-
ing intoxication and withdrawal. Studies have reported
reductions in depressive symptoms during substance use
treatment [22,23]. Reductions in depressive symptoms
may also occur relatively rapidly after admission to both
alcohol and opiate dependence treatment programs, as
patients pass through acute intoxication and withdrawal
states [24-26]. Also, symptoms of anxiety at admission
to substance use treatment among alcohol dependent
patients have been shown to spontaneously recede dur-
ing treatment [27].
Failure to treat a concurrent psychiatric disorder re-
duces the likelihood that the treatment for SUD will be
effective and can lead to negative consequences in a life
time perspective [7,28,29]. It has been claimed that pa-
tients with psychiatric disorders often go undiagnosed
and untreated for their psychiatric disorders through
substance use treatment [30]. In a nationwide study of
patients undergoing substance use treatment in Norway
[31], only 25% of the patients were given a diagnosis
according to the ICD-10 diagnostic system. An accurate
diagnosis and a successful treatment of SUDs and co-
occurring psychiatric disorders relies on a careful, compre-
hensive assessment [32], which can provide the necessary
information for intervention and treatment planning. A
careful and comprehensive assessment can also engage
the patient and provide motivation to begin the process of
change [33].
The aim of the present study
This was the first study on substance use and co-
occurring psychiatric disorders in one catchment area in
Northern Norway including patients involving several
units [34-37]. In this study, we wanted to investigate to
which extent co-occurring psychiatric disorders were di-
agnosed in a clinical population of substance abusers.
We were also interested in factors influencing diagnostic
practice, and to which extent diagnostic practice varied
with the variables that we had data on [38]. We hypoth-
esized that there would be differences in diagnostic
practice according to which extent a systematic diag-
nostic tool (i.e. the MINI-Plus) was used. We alsohypothesized that a higher level of mental distress at ad-
mission to treatment predicted a diagnosis of a co-
occurring psychiatric disorder. We wanted to address
these hypotheses by investigating the following research
questions:
1. What characterized patients in five different
treatment units with regard to gender and age,
substance use, independent psychiatric disorders,
use of a diagnostic tool, and mental distress?
2. Did the use of a diagnostic tool (i.e. the MINI-
Plus) predict the diagnosing of independent
psychiatric disorders in this sample, when
controlling for age, gender, use of substances, and
mental distress?
Methods
Substance use treatment in Northern Norway
The five substance use treatment units participating in
this study covered a population of 500 000 inhabitants
in north Norway. All units were inpatient units at the
University Hospital of Northern Norway. Inpatient care
is the typical treatment setting for patients with SUD in
northern Norway [39]. The Dual diagnosis ward offered
specialized assessment and treatment of dual diagnoses
and provided treatment up to six months. The Thera-
peutic community provided treatment up to 18 months
according to a therapeutic community model. The
Short-term unit was a detoxification unit that provided
treatment up to six weeks. Long-term unit 1 and 2 pro-
vided general SUD inpatient treatment up to six months.
All units treated both sexes, used a combination of
group and individual therapy, and managed detoxi-
fication either directly or in collaboration with a detoxi-
fication unit. Treatment was composed of a combination
of network-based approaches, psychotherapeutic and
pharmacological treatments, but these components were
given different emphasis in the various units. Character-
istics of the patients within the different units are
presented in Table 1.
Data collection procedures and participation rates
The study was based on a naturalistic design with mea-
surements taken at admission to treatment and during
treatment. All patients admitted to the units and consid-
ered competent to consent during the period September
2007 to May 2009 were given written and oral informa-
tion about the study by a research collaborator working
in each unit. Shortly following their consent to partici-
pate they responded to a questionnaire. During treat-
ment, the patient’s clinician gave socio-demographic
information (i.e. age and gender) and information about
diagnostic procedures and outcome. Patients were paid
compensation in the form of a cinema ticket or two
Table 1 Demographics, diagnoses, diagnostic practice, mental distress, and substance use according to unit
Unit Dual diagnosis





unit (N = 87)
Long-term
unit 1 (N = 68)
Long-term
unit 2 (N = 68)
Total, mean
value (N = 275)
Mean age (SD) 27.75 (7.73)*** 26.83 (6.32)*** 39.17 (12.19) 43.38 (9.28)*** 42.6 (10.75)** 38.79 (11.79)
Female 20% (4) 40.6% (13 ) 26.4% (23) 26.5% (18) 25% (17) 27.3% (75)
MINI-Plus used 60% (12) 34.4% (11) 19.5% (17)*** 45.6% (31) 69.1% (47)*** 42.9% (118)
Independent psychiatric disorder 80% (16)*** 34.4% (11) 19.5% (17)** 23.5% (16) 41.2% (28) 32% (88)
Anxiety disorder 40% (8)** 6.3% (2) 6.9% (6)* 16.2% (11) 20.6% (14) 14.9% (41)
Mood disorder 5% (1) 31.3% (10)** 9.2% (8) 1.5% (1)** 22.1% (15)** 12.7% (35)
Mean score HSCL-10 (SD) 2.86 (0.73)* 2.71 (0.43)* 2.71 (0.63)** 2.32 (0.8)** 2.35 (0.77)* 2.53 (0.73)
Mean score DUDIT (SD) 29.0 (9.84)*** 35.28 (7.49)*** 21.28 (15.83) 10.28 (13.81)*** 12.56 (14.78)*** 18.59 (16.14)
Mean score AUDIT (SD) 15.6 (9.7) 13.72 (10.9)* 14.4 (12.76)** 22.34 (10.02)*** 19.74 (11.63) 17.69 (11.86)
*p < 0.05; **p < 0.01, ***p < 0.0001. T-tests and chi-square tests.
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the Regional Committee for Medical Research Ethics
(P REK Nord 12/2006) and the Norwegian Social Science
Data Services (NSD).
In the study period, 574 patients were admitted to the
units. Patients who were considered not able to give an
informed consent (N = 21) or whose hospital stay was
too short to be included (N = 41) were not asked to par-
ticipate. Of the patients considered relevant for the study
(N = 512), 296 patients (58%) agreed to participate and
signed an informed consent. Of these, 275 participants
filled in the questionnaire at admission to treatment and
are thus included in the analyses (73% men, mean age
39, range 18 – 79 years). More than 90% of the sample
had a Norwegian origin.
Outcome variable
All patients admitted to treatment in Norwegian hospi-
tals are, at discharge, routinely given one or more diag-
noses according to the ICD-10 system [40]. In this
study, the diagnoses the participants were given were
obtained from the patients’ clinicians. The clinicians
used a standardized diagnostic tool (MINI-Plus), which
a short time before the study started had been
implemented for routine use in the units. However, not
all clinicians used the MINI-Plus, and some preferred
making a diagnostic assessment based on clinical judge-
ment according to ICD-10 criteria. We were interested
in the independent psychiatric diagnoses the participants
were given that were not related to substance use. The
participants were divided into two diagnostic categories:
those who had obtained no other diagnosis than a SUD-
diagnosis (F10-19) (N = 187), and those who had
obtained one or more additional ICD-10 diagnoses
(F20-99) (N = 88). Diagnostic category (i.e. the presence
of a psychiatric diagnosis or not) was the outcome vari-
able in the logistic regression analyses.Explanatory variables
Mental distress was measured at admission to treatment
using a 10-item version of the Hopkins Symptom Check-
List (HSCL-10) [41]. The HSCL-10 is a self-report ques-
tionnaire with a four point Likert scale, ranging from 1
(not at all) to 4 (extremely). The HSCL-10 is based on the
SCL-90-R [42], and is composed of two out of the original
nine factors (anxiety and depression) [43]. A mean item
score was calculated and used as an index of general dis-
tress severity (Global Severity Index). A mean score of
1.85 or higher generally indicates a need of further assess-
ment and possibly a need for psychiatric treatment [41].
Substance use was measured by the Alcohol Use Dis-
orders Identification Test (AUDIT) [44] and the Drug
Use Disorders Identification Test (DUDIT) [45]. The
AUDIT is a widespread instrument measuring severity
of alcohol use the past 12 months. It has 10 items with a
scoring range from 0 to 40. The DUDIT is a parallel in-
strument to the AUDIT and is designed to identify per-
sons with drug use disorders the past 12 months. It has
11 items with a scoring range from 0 to 44. Both the
AUDIT and the DUDIT were used as continuous vari-
ables (i.e. without cut-off values).
The Norwegian National Client Assessment Form,
which is routinely completed for all patients admitted to
SUD treatment in Norway [46], was used to assess pa-
tients’ age and gender.
The patients’ clinicians provided extended information
on the patients’ diagnostic assessment through a form
developed especially for this study, including reporting
the use of the diagnostic instrument MINI-Plus (Mini
International Neuropsychiatric Interview-Plus). MINI-
Plus is an extended version of the MINI [47] that is a
structured interview for psychiatric disorders according
to DSM-IV and ICD-10. MINI-Plus employs in addition
different time frames for various disorders: current, past
or lifetime [48].
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T-tests (for continuously scaled variables) and chi-
squared tests (for dichotomous variables) were used to
compare the participants in the different units, and later
those who had obtained an independent psychiatric dis-
order with those who had not. The groups were com-
pared on age, gender, whether or not they were assessed
by the use of MINI-Plus, mental distress (measured by
the HSCL-10) and substance use (measured by the
AUDIT and the DUDIT). In the t-test analyses, the mean
value of each unit was compared to the mean value of
the other units.
The outcome variable was dichotomous, and a hier-
archical binary logistic regression analysis was conducted
to analyze associations between diagnosis and use of the
diagnostic instrument MINI-Plus and mental distress,
controlling for age, gender, and substance use (score on




Of the 275 participating patients, 88 (32%) were given
an independent psychiatric disorder during treatment by
the responsible clinician. 118 (42.9%) of the patients had
been assessed by means of the MINI-Plus, the rest had
been assessed by means of clinical judgement supported
by ICD-10 criteria. The most common non-SUD diagno-
ses were anxiety disorders (15%) and mood disorders
(13%). In addition, a few patients (4%) had other non-
SUD diagnoses, such as ADHD, personality disorders, or
schizophrenia. The most common SUD-diagnoses were
alcohol dependence syndrome (45%), opioid dependency
(23%), and dependency of other stimulants (12%). There
were significant differences between the use of a system-
atic diagnostic tool (MINI-Plus) between the units, and
also significant differences between the patients admitted
to the different units (Table 1).
Compared to the overall mean values, the participants
in the Dual diagnosis ward were younger, more often
had an independent psychiatric disorder, more often had
an anxiety disorder, and reported a higher score onTable 2 Univariate analyses of patients who received an inde
Total all N = 275 Ind
diso
Age (SD) 38.8 (11.8) 34.2
Female 27.3% (75) 36.4
MINI-Plus used 118 (42.9%) 70.5
Mental distress at admission (HSCL-10) 2.53 (.73) 2.65
AUDIT 17.69 (11.86) 15.6
DUDIT 18.59 (16.14) 21.8
*p < .05; **p < .0001.HSCL-10 and a higher score on the DUDIT. Compared
to the overall mean values, the participants from the
Therapeutic community were younger, more often had a
mood disorder, reported a higher score on the DUDIT
and the HSCL-10, and a lower score on the AUDIT.
Compared to the overall mean values, the MINI-Plus
was less often used in the Short term unit, and the par-
ticipants were less often given a diagnosis of an inde-
pendent psychiatric disorder and less often given a
diagnosis of an anxiety disorder. The participants also
reported a higher score on the HSCL-10, and a lower
score on the AUDIT. Compared to the overall mean
values, the participants in Long term unit 1 were older.
They were more seldom given a diagnosis of mood dis-
order, and reported a lower score on the HSCL-10 and
the DUDIT and a higher score on the AUDIT. Com-
pared to the overall mean values, the participants in the
Long term unit 2 were also older. The MINI-Plus was
used more often in this unit, and the participants were
more often given a diagnosis of a mood disorder. The
participants in Long term unit 2 reported a lower score
on the HSCL-10 and the DUDIT.
Table 2 reports the results of the univariate analyses of
the patients given an independent psychiatric disorder
versus the patients given no independent psychiatric dis-
order. Compared to those who only had a SUD-
diagnosis, patients who had an independent psychiatric
disorder reported a higher score on the DUDIT, were
more often female, and were more often assessed by a
diagnostic instrument.
Factors predicting diagnostic practice
A hierarchical logistic regression analysis was performed
to identify predictors of a psychiatric diagnosis other
than substance use disorder. Based on the univariate
analyses, we investigated interactions between the use of
MINI-Plus and the treatment units. A significant inter-
action between the use of MINI-Plus and the Short-
Term Unit, Long Term Unit 1 and the Therapeutic
community emerged. We thus decided to exclude all fa-
cilities as variables in the final analysis. The predictors
were entered in three steps: 1) the use of a diagnosticpendent psychiatric disorder versus patients who did not
ependent psychiatric
rder 32% (N = 88)
Only SUD- diagnosis
68% (N = 187)
p
(10.5) 41.0 (11.8) t = 4.6**
% (32) 23% (43) x2(1) = 5.4*
% (62) 29.9% (56) x2(1) = 40.1**
(.70) 2.48 (.73) ns
8 (10.99) 18.64 (12.16) ns
0 (15.67) 17.09 (16.18) t = −2.3*
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and 3) controlling for age, gender, and substance use
(AUDIT and DUDIT). A total of 275 cases were analyzed
and the full model significantly predicted a psychiatric
diagnosis other than SUD (omnibus chi-square = 71.58,
df = 6, p < 0.0001). The model accounted for between
22.9% and 32.1% of the variance in independent psychi-
atric disorders, with 88.8% of the non-additional diagno-
ses successfully predicted. Also, 50.0% of the additional
diagnoses were successfully predicted. Overall, 76.4% of
the predictions were successful. Table 3 gives coefficients,
the Wald statistics, and probability values for each of the
predictor variables. This shows that the use of the diag-
nostic instrument MINI-Plus predicted the setting of an
independent psychiatric disorder, in addition to the con-
trol variables lower age and a lower use of alcohol as
measured by the AUDIT.
Discussion
This study of diagnostic practice in five substance use
units in northern Norway showed that one third of the
patients were given an independent psychiatric diagnosis.
The main predictor of the diagnosing of independent
psychiatric diagnoses was the use of a systematic diag-
nostic tool (MINI-Plus). Younger age and less use of al-
cohol as measured by the AUDIT [44] were also
associated with independent psychiatric diagnoses.
We used diagnoses of independent psychiatric disor-
ders as the outcome measure, as we were interested in
how clinicians diagnosed patients with substance use
disorders. Previous research has shown that substance
use disorders and other psychiatric disorders to a great
extent appear simultaneously [3-5]. We found a lower
number of independent psychiatric diagnoses in our
study compared to previous research using standardized
diagnostic instruments [18]. This finding is probably due
to the fact that the diagnoses in our study most often
were based on clinical judgement. In substance use
treatment, naturally, the main focus is on substance use
disorders, and there could be a tendency to overlook co-
occurring psychiatric disorders [32]. This finding is in
line with previous research that reports that patients
with psychiatric disorders often go undiagnosed and un-
treated through substance use treatment [30]. The most
common non-SUD diagnoses were anxiety and moodTable 3 Logistic regression analysis of factors predicting
diagnostic practice
B SE Wald p OR 95% CI
for OR
MINI-Plus used 1.970 .317 38.554 .0001 7.172 3.851-13.358
Age -.057 .017 11.585 .001 .945 .915-.976
Use of alcohol (AUDIT) -.030 .015 4.031 .045 .971 .943-.999disorders, as found in previous studies. The proportion
of patients with these diagnoses was nevertheless much
lower compared to other studies [18]. In one other
Norwegian study, 78% of the patients had been given a
diagnosis of a mood disorder and 36% had received a
diagnosis of major depression [18]. In our study, only
15% had been given a diagnosis of an anxiety disorder
and only 13% a diagnosis of a mood disorder.
This study revealed significant differences between the
different units, concerning most of the variables studied
(Table 1). Independent psychiatric disorders were signifi-
cantly more often identified in the Dual diagnosis ward,
and less often in the Short-term unit. This is probably
not surprising given that the Dual diagnosis ward is spe-
cialized in treating exactly such a patient group, meaning
that patients with dual diagnoses are channeled to this
ward and that there is a stronger focus on dual diagno-
ses in this ward. On the other hand, independent mood
disorders were identified in only 5% of the patient in this
unit. This is more seldom than in the general population
[4]. The Short-term ward deals more with detoxification
and refers patients to other units for further assessment
and treatment. They also used the standardized diagnos-
tic tool MINI-Plus significantly less often than the other
units, probably due to time constraints and a high pro-
portion being in a phase of detoxification. A more sur-
prising and less obvious fact was to which degree the
proportion of patients that were given the most common
independent psychiatric disorders (anxiety and mood
disorders) varied between the units. Anxiety disorders
were overall the most common independent psychiatric
disorders. This is consistent with other studies, even
though the proportion was much lower here than in
other studies [18]. Diagnoses of anxiety disorders were
more often used in the Dual diagnosis ward, and less
often in the Short-term unit. This pattern follows the
pattern of independent psychiatric disorders as such.
Mood disorders were more often diagnosed in the
Therapeutic community and in Long-term unit 2, and
less often in Long-term unit 1. Also, only one of the pa-
tients in the Dual diagnosis ward was given a diagnosis
of mood disorder. Clinicians at Long-term unit 2 used
the MINI-Plus significantly more often than the clini-
cians in the other units. The two Long-term units only
differed when it came to the use of MINI-Plus and the
diagnosing of mood disorders. It is difficult to under-
stand the varying use of MINI-Plus as anything but an
expression of different cultures or treatment philoso-
phies in the various units [49].
As previously reported from this study, the level of
mental distress according to HSCL-10 was high in this
sample [34]. The cut-off point generally agreed on is
1.85 [41]. In this sample, the mean score varied between
2.32 (Long-term unit 1) and 2.86 (the Dual diagnosis
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level of mental distress reported was significantly higher
in the Dual diagnosis ward, the Therapeutic community
and the Short-term unit, and significantly lower in the
two Long-term units. This pattern is comparable with
the pattern of use of alcohol and other substances. A
higher level of mental distress at admission to treatment
was related to less heavy use of alcohol and more
heavy use of other substances. This is consistent with
previous research that finds a greater incidence of in-
dependent psychiatric disorders among patients with
drug use disorders compared to patients with alcohol
use disorders [10].
In this study, younger patients more often received a
diagnosis of an independent psychiatric disorder in
addition to their substance abuse diagnosis. We also
found an association between less heavy use of alcohol
as measured by the AUDIT [44] and independent psy-
chiatric disorders. We did not find that drug use as mea-
sured by the DUDIT predicted the setting of non-SUD
disorders. While some previous research has suggested
that psychiatric disorders appear less often for those
with an alcohol related disorder compared with those
with drug use disorders [3-6,8,50], this was not the case
in our study. Previous publications from the present
study have shown that participants with alcohol related
disorders in this sample were older than those with drug
use disorders [34]. The variable gender was not signifi-
cant, which is interesting since prior studies have found
that the gender of the patient is an important factor with
respect to both the distribution of mental disorders [10]
and diagnostic practice [38].
Level of mental distress had no significant impact on
the diagnosing of independent psychiatric disorders.
One would expect level of mental distress to be an im-
portant factor, and that patients with high levels of men-
tal distress would be more likely to receive additional
psychiatric diagnoses, especially diagnoses related to de-
pression and anxiety. It is possible that the level of men-
tal distress at admission to treatment in this sample was
so high that it did not differentiate between those who
should receive a psychiatric diagnosis and those who
should not.
Using the MINI-Plus increased the chance of the pa-
tient receiving a second diagnosis. Structured interviews
have been shown to increase the diagnostic validity of
SUD-diagnoses compared to clinical judgements, but the
validity of structured interviews for detecting co-
occurring psychiatric diagnoses has been questioned
[51,52]. In the present study, the clinicians who chose to
use the MINI-Plus had likely suspected that the patients
had co-occurring psychiatric disorders. We believe that
psychiatric disorders in this population often are
overlooked. The findings that patients admitted to aspecific ward and/or subjected to investigation by the
MINI-Plus more often received additional psychiatric
diagnoses, may support this idea.Strengths and limitations
This is one of only a few studies in Norway that have
surveyed independent psychiatric disorders among sub-
stance abusers in treatment, and the first in the northern
part of Norway. Our study covered the range of treat-
ment facilities that is most commonly offered substance
abusers in the area. Northern Norway is a relatively well
defined catchment area where most of the treatment is
given in inpatient settings.
The present study is subject to a number of limita-
tions. The participation rate was 58%. While the rate is
not particularly low for this type of study, it might
nevertheless impact the representativity of the findings.
In addition, the study sample was selected from five dif-
ferent units for inpatient SUD treatment. The units dif-
fered substantially - one unit was primarily concerned
with detoxification, one unit focused on the assessment
of dual diagnosis patients, and three units offered a more
goal directed SUD treatment. As type of treatment unit
was excluded from the regression analysis due to inter-
action effects, we are unable to make any claims about
the importance of type of treatment unit on diagnostic
practice. We also lack information on the clinicians that
made the assessments. There is, therefore, some hetero-
geneity within the sample. A further limitation is that
the study lacks an untreated control condition, although
this is extremely difficult to construct in this study set-
ting. On the other hand, multisite, prospective studies
like the present can investigate treatment outcomes in
existing services and under actual clinical circumstances,
and thereby show a high external validity and allow for a
generalization of the findings to clinical settings [53].Conclusions
One third of the patients were given an independent
psychiatric diagnosis, which was low compared to other
studies using standardized diagnostic tools. In this study,
less than half of the patients were assessed using a diag-
nostic tool. The main predictor of diagnosing of inde-
pendent psychiatric disorders was the use of the
diagnostic tool MINI-Plus. Younger patients and pa-
tients that used less alcohol, were given independent
psychiatric diagnoses more frequently. The low number
of patients assessed by a standardized diagnostic tool,
and the strong relationship between the use of a diag-
nostic tool and the diagnosing of co-occurring diagno-
ses, suggest that the implementation of standardized and
validated diagnostic tools should be addressed in the
units involved in the study. In order to provide good
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amined for non-SUD disorders.
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